![]() |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Prevalence and Risk Factors for Pathologic N2 Disease in Resected Lung Cancers
Assessed as N0 or N1 Disease on Preoperative Imaging.
AJR Am J Roentgenol. 2025 Feb 19. doi: 10.2214/AJR.24.32486.
PubMed
Abstract available
ASO Visual Abstract: Longitudinal Trajectory of Patient-Reported Fatigue in
Patients Undergoing Thoracoscopic Lung Cancer Surgery.
Ann Surg Oncol. 2025 Jun 9. doi: 10.1245/s10434-025-17574.
PubMed
Early radiotherapy improved survival of patients with extensive-stage small cell
lung cancer treated with first-line chemo-immunotherapy.
BMC Cancer. 2025;25:1012.
PubMed
Abstract available
National variation in the treatment of lung cancer in a universal healthcare
context.
Br J Cancer. 2025 Jun 6. doi: 10.1038/s41416-025-03071.
PubMed
Abstract available
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors
reveals TIM-3 as a putative target for precancer interception.
Cancer Cell. 2025;43:1125-1140.
PubMed
Abstract available
Immune evolution in pre-invasive lung adenocarcinoma.
Cancer Cell. 2025;43:1004-1006.
PubMed
Abstract available
Stromal lipid species dictate melanoma metastasis and tropism.
Cancer Cell. 2025;43:1108-1124.
PubMed
Abstract available
Lactate accumulation drives hepatocellular carcinoma metastasis through
facilitating tumor-derived exosome biogenesis by Rab7A lactylation.
Cancer Lett. 2025;627:217636.
PubMed
Abstract available
Dauricine Overcomes Osimertinib Resistance in Lung Cancer by Inducing Ferroptosis
via Stabilizing SAT1.
Cancer Sci. 2025 Jun 8. doi: 10.1111/cas.70113.
PubMed
Abstract available
Pulmonary Subsolid Nodules: Upfront Surgery or Watchful Waiting?
Chest. 2025;167:1764-1777.
PubMed
Abstract available
Evolution of Diffusing Capacity of the Lungs for Carbon Monoxide in
Lymphangioleiomyomatosis: Historical Perspectives and the Role of Advanced
Imaging.
Chest. 2025;167:1705-1713.
PubMed
Abstract available
Round-Robin Comparison of RET Rearrangement Detection in ctDNA: A Novel Method
for Limited Clinical Samples.
Clin Cancer Res. 2025;31:2406-2412.
PubMed
Abstract available
Finding Rearrangements in the Cell-Free DNA Haystack.
Clin Cancer Res. 2025;31:2264-2266.
PubMed
Abstract available
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous
Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
Clin Lung Cancer. 2025 May 22:S1525-7304(25)00076.
PubMed
Abstract available
Mortality in a Diverse, Real-World Lung Cancer Screening Cohort.
Clin Lung Cancer. 2025 May 13:S1525-7304(25)00102.
PubMed
Abstract available
Combined Impact of Coronary Artery Calcification and Heart Radiation Dose on
Overall Survival in Locally Advanced Non-Small Cell Lung Cancer: Who Benefits
Most from Reducing Heart Radiation Dose?
Clin Lung Cancer. 2025 May 12:S1525-7304(25)00100.
PubMed
Abstract available
Prevalence and anatomical characteristics of the left medial basal pulmonary
segment: a retrospective cohort study using three-dimensional computed tomography
reconstruction.
Eur J Cardiothorac Surg. 2025;67:ezaf165.
PubMed
Abstract available
Plasma proteomic profiles for early detection and risk stratification of
non-small cell lung carcinoma: A prospective cohort study with 52,913
participants.
Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35518.
PubMed
Abstract available
Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive
Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641.
PubMed
Abstract available
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for
Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All
Paradigm.
Int J Radiat Oncol Biol Phys. 2025;122:739-751.
PubMed
Abstract available
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20
Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With
Platinum-Based Chemotherapy With or Without Amivantamab.
J Clin Oncol. 2025 Jun 1:JCO2500763. doi: 10.1200/JCO-25-00763.
PubMed
Abstract available
Engineered allogeneic stem cells orchestrate T lymphocyte driven immunotherapy in
immunosuppressive leptomeningeal brain metastasis.
J Natl Cancer Inst. 2025 Jan 22:djaf006. doi: 10.1093.
PubMed
Abstract available
AYVM to AYMM Transition on HER2 Exon 20 Insertion Induces Tyrosine Kinase
Inhibitor Resistance in NSCLC.
J Thorac Oncol. 2025;20:739-749.
PubMed
Abstract available
Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From
SKIPPirr, a Phase 2 Study: A Brief Report.
J Thorac Oncol. 2025;20:809-816.
PubMed
Abstract available
Can Immunotherapy Be Omitted in KRAS G12C-Mutant Lung Cancer by 2025?
J Thorac Oncol. 2025;20:692-694.
PubMed
Bridging the Gap in Surgery for Octogenarians With Early-Stage Lung Cancer.
J Thorac Oncol. 2025;20:703-704.
PubMed
Overcoming Barriers to Lung Cancer Screening: The Incidental Pulmonary Nodule
Strategy.
J Thorac Oncol. 2025;20:705-707.
PubMed
Quality Performance Indicators for Lung Cancer Screening: Towards the Next
Levels?
J Thorac Oncol. 2025;20:e68-e69.
PubMed
A Response to the Letter to the Editor: "Quality Performance Indicators for Lung
Cancer Screening: Towards the Next Levels?".
J Thorac Oncol. 2025;20:e69-e71.
PubMed
Shared decision making for personalized lung cancer care.
Lung Cancer. 2025 Jun 9:108614. doi: 10.1016/j.lungcan.2025.108614.
PubMed
Geographic disparities in lung cancer screening uptake in the United States using
the 2021 United States Preventive Services Task Force Guidelines.
Lung Cancer. 2025;205:108615.
PubMed
Abstract available
Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world
response patterns and survival outcomes.
Lung Cancer. 2025;205:108598.
PubMed
Abstract available
Survival and prognostic factors of HER2-mutant advanced non-small cell lung
cancer with brain metastases.
Lung Cancer. 2025;205:108616.
PubMed
Abstract available
AGREE-II appraisal of lung cancer management clinical practice guidelines by the
OPTIMA consortium.
Lung Cancer. 2025;205:108610.
PubMed
Abstract available
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth
factor receptor-mutant stage III non-small cell lung cancer: A Japanese
Real-World data analysis.
Lung Cancer. 2025;205:108597.
PubMed
Abstract available
LINC02562 Promotes Progression of Lung Cancer by Regulating NTHL1 Dependent DNA
Damage Repair Mechanisms.
Mol Carcinog. 2025 Jun 11. doi: 10.1002/mc.23935.
PubMed
Abstract available
ZNF768 loss amplifies p53 action and reduces lung tumorigenesis in mice.
Oncogene. 2025;44:1793-1804.
PubMed
Abstract available
Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for
first-line treatment of extensive-stage small cell lung cancer.
PLoS One. 2025;20:e0325171.
PubMed
Abstract available
Improving lung cancer diagnosis and survival prediction with deep learning and CT
imaging.
PLoS One. 2025;20:e0323174.
PubMed
Abstract available
Thionated levofloxacin derivative: Potential repurposing for cancer treatment and
synergism with doxorubicin on doxorubicin-resistant lung cancer cells.
PLoS One. 2025;20:e0324930.
PubMed
Abstract available
Acquired resistance to immunotherapy by physical barriers with cancer
cell-expressing collagens in non-small cell lung cancer.
Proc Natl Acad Sci U S A. 2025;122:e2500019122.
PubMed
Abstract available
CRISPR screens and quantitative proteomics reveal remodeling of the aryl
hydrocarbon receptor-driven proteome through PARP7 activity.
Proc Natl Acad Sci U S A. 2025;122:e2424985122.
PubMed
Abstract available
Aberrant basal cell clonal dynamics shape early lung carcinogenesis.
Science. 2025;388:eads9145.
PubMed
Abstract available
Towards dynamic risk assessments in lung cancer screening.
Thorax. 2025 Jun 8:thorax-2025-223403. doi: 10.1136/thorax-2025-223403.
PubMed
Thank you for your interest in scientific medicine.